HOUSE DOCKET, NO. 2578        FILED ON: 1/19/2017

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 2397

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Kevin J. Kuros

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act creating a commission to study increasing access to naloxone.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

Kevin J. Kuros

8th Worcester

1/19/2017

Timothy R. Whelan

1st Barnstable

11/7/2017

Joseph D. McKenna

18th Worcester

11/7/2017

Ryan C. Fattman

Worcester and Norfolk

11/7/2017

William L. Crocker, Jr.

2nd Barnstable

11/7/2017

Shawn Dooley

9th Norfolk

2/2/2017

Bradley H. Jones, Jr.

20th Middlesex

11/7/2017

Angelo L. D'Emilia

8th Plymouth

11/7/2017

Hannah Kane

11th Worcester

11/7/2017

David F. DeCoste

5th Plymouth

11/7/2017

Thomas J. Calter

12th Plymouth

11/7/2017

Paul K. Frost

7th Worcester

11/7/2017

Michael S. Day

31st Middlesex

11/7/2017

Bruce E. Tarr

First Essex and Middlesex

11/7/2017


HOUSE DOCKET, NO. 2578        FILED ON: 1/19/2017

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 2397

By Mr. Kuros of Uxbridge, a petition (accompanied by bill, House, No. 2397) of Kevin J. Kuros and others for an investigation by a special commission (including members of the General Court) of alternatives to naloxone and to broaden the availability of naloxone.  Mental Health, Substance Use and Recovery.

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninetieth General Court
(2017-2018)

_______________

 

An Act creating a commission to study increasing access to naloxone.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Notwithstanding any special or general law there shall be a special commission to study the alternatives and develop recommendations to broaden the availability of naloxone without prescription, including but not limited to recommendations on the standing order process, the collaborative practice agreement process, and/or legislative recommendations.

The special commission shall consist of: the secretary of health and human services or their designee, who shall serve as chair; the commissioner of the division of insurance or their designee; three members to be appointed by the governor, which shall include: one person who is a prescribing physician, one person who is a stakeholder within a retail pharmacy company, and one member of the general citizenry impacted by the opiate epidemic; two members of the house of representatives, one of whom to be appointed by the minority leader; two members of the senate, one of whom to be appointed by the minority leader; the director of the board of pharmacy or their designee; the director of the bureau of substance abuse services or their designee; provided, however, that the first meeting of the commission shall take place not later than January 1, 2018.

The special commission shall submit its recommendations, together with drafts of any legislation, to the clerks of the house of representative and the senate, the chairs of the joint committee on mental health and substance abuse not later than May 1, 2018.